Metabolite

KNApSAcK Entry

id C00030922
Name Panaxydol / (-)-Panaxydol
CAS RN 72800-72-7
Standard InChI InChI=1S/C17H24O2/c1-3-5-6-7-10-13-16-17(19-16)14-11-8-9-12-15(18)4-2/h4,15-18H,2-3,5-7,10,13-14H2,1H3/t15-,16+,17-/m1/s1
Standard InChI (Main Layer) InChI=1S/C17H24O2/c1-3-5-6-7-10-13-16-17(19-16)14-11-8-9-12-15(18)4-2/h4,15-18H,2-3,5-7,10,13-14H2,1H3

Cluster

Phytochemical cluster
KCF-S cluster No. 3682

Link

ChEMBL

By standard InChI
By standard InChI Main Layer

KEGG

By LinkDB

CTD

By CAS RN C055778

Human Protein / Gene in interaction

CTD interaction (8)

compound gene gene name gene description interaction interaction type form reference
pmid
C055778 174 AFP
FETA
HPAFP
alpha-fetoprotein panaxydol results in decreased secretion of AFP protein decreases secretion
protein 19450571
C055778 213 ALB
PRO0883
PRO0903
PRO1341
albumin panaxydol results in increased secretion of ALB protein increases secretion
protein 19450571
C055778 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) panaxydol results in increased expression of CDKN1A mRNA increases expression
mRNA 19450571
C055778 1026 CDKN1A
CAP20
CDKN1
CIP1
MDA-6
P21
SDI1
WAF1
p21CIP1
cyclin-dependent kinase inhibitor 1A (p21, Cip1) panaxydol results in increased expression of CDKN1A protein increases expression
protein 19450571
C055778 3397 ID1
ID
bHLHb24
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein panaxydol results in decreased expression of ID1 mRNA decreases expression
mRNA 19450571
C055778 3398 ID2
GIG8
ID2A
ID2H
bHLHb26
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein panaxydol results in decreased expression of ID2 mRNA decreases expression
mRNA 19450571
C055778 5925 RB1
OSRC
RB
p105-Rb
pRb
pp110
retinoblastoma 1 panaxydol results in increased expression of RB1 protein increases expression
protein 19450571
C055778 5925 RB1
OSRC
RB
p105-Rb
pRb
pp110
retinoblastoma 1 panaxydol results in increased expression of RB1 protein modified form increases expression
protein 19450571

Related Disease

Diseases related to CTD interactions

1 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D006528 C055778 Carcinoma, Hepatocellular therapeutic
19450571